Susquehanna Fundamental Investments, LLC Forma Therapeutics Holdings, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $292,325 - $830,993	-41,057 Reduced 71.68%	16,218 $324,000
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $266,940 - $488,540	19,628 Added 52.14%	57,275 $814,000
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $519,720 - $629,444	24,492 Added 186.18%	37,647 $873,000
Q2 2021 Aug 11, 2021	BUY	$22.86 - $30.95 $300,723 - $407,147	13,155 New	13,155 $327,000
Q1 2021 May 17, 2021	SELL	$24.58 - $42.82 $164,563 - $286,679	-6,695 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$34.9 - $51.08 $581,503 - $851,094	-16,662 Reduced 71.34%	6,695 $234,000
Q3 2020 Nov 16, 2020	BUY	$32.95 - $50.25 $769,613 - $1.17 Million	23,357 New	23,357 $1.16 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.